Michael Stallings
Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 42 | 2025 | 1072 | 4.000 |
Why?
| | Alcoholism | 29 | 2025 | 804 | 2.870 |
Why?
| | Diseases in Twins | 15 | 2019 | 175 | 2.440 |
Why?
| | Genome-Wide Association Study | 21 | 2025 | 1434 | 2.440 |
Why?
| | Twins | 20 | 2023 | 253 | 2.310 |
Why?
| | Antisocial Personality Disorder | 20 | 2025 | 169 | 2.090 |
Why?
| | Sexual Behavior | 6 | 2024 | 485 | 2.010 |
Why?
| | Conduct Disorder | 19 | 2023 | 201 | 1.900 |
Why?
| | Genetic Predisposition to Disease | 29 | 2025 | 2417 | 1.660 |
Why?
| | Tobacco Use Disorder | 9 | 2025 | 252 | 1.650 |
Why?
| | Alcohol Drinking | 16 | 2022 | 818 | 1.560 |
Why?
| | Gambling | 2 | 2020 | 33 | 1.260 |
Why?
| | Siblings | 16 | 2025 | 228 | 1.250 |
Why?
| | Polymorphism, Single Nucleotide | 24 | 2025 | 2190 | 1.250 |
Why?
| | Adolescent Behavior | 18 | 2018 | 534 | 1.180 |
Why?
| | Cocaine-Related Disorders | 2 | 2020 | 113 | 1.170 |
Why?
| | Impulsive Behavior | 5 | 2024 | 149 | 1.120 |
Why?
| | Phenotype | 28 | 2025 | 3199 | 1.100 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 7 | 2015 | 75 | 1.030 |
Why?
| | Marijuana Abuse | 13 | 2020 | 233 | 0.970 |
Why?
| | Adolescent | 89 | 2025 | 21463 | 0.940 |
Why?
| | Smoking | 15 | 2019 | 1633 | 0.860 |
Why?
| | Twins, Dizygotic | 14 | 2024 | 183 | 0.850 |
Why?
| | Mental Disorders | 8 | 2021 | 1075 | 0.820 |
Why?
| | Environment | 15 | 2015 | 362 | 0.770 |
Why?
| | Risk-Taking | 7 | 2024 | 348 | 0.730 |
Why?
| | Personality | 6 | 2021 | 130 | 0.720 |
Why?
| | Young Adult | 35 | 2025 | 13126 | 0.720 |
Why?
| | Age of Onset | 3 | 2019 | 518 | 0.710 |
Why?
| | Genetic Variation | 6 | 2022 | 985 | 0.710 |
Why?
| | Academic Success | 1 | 2021 | 28 | 0.690 |
Why?
| | Male | 93 | 2025 | 67361 | 0.680 |
Why?
| | Temperament | 3 | 2019 | 46 | 0.680 |
Why?
| | Twins, Monozygotic | 14 | 2024 | 212 | 0.670 |
Why?
| | Female | 93 | 2025 | 72840 | 0.640 |
Why?
| | Feeding and Eating Disorders | 4 | 2024 | 152 | 0.630 |
Why?
| | Humans | 128 | 2025 | 136783 | 0.620 |
Why?
| | Adult | 56 | 2025 | 37616 | 0.620 |
Why?
| | Genotype | 19 | 2019 | 1919 | 0.620 |
Why?
| | Child Abuse | 3 | 2021 | 546 | 0.570 |
Why?
| | Juvenile Delinquency | 7 | 2018 | 109 | 0.560 |
Why?
| | Longitudinal Studies | 26 | 2025 | 2847 | 0.560 |
Why?
| | Anxiety Disorders | 2 | 2019 | 374 | 0.520 |
Why?
| | Models, Genetic | 11 | 2024 | 605 | 0.510 |
Why?
| | Depressive Disorder, Major | 2 | 2020 | 360 | 0.490 |
Why?
| | Psychological Theory | 3 | 2013 | 97 | 0.490 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 455 | 0.490 |
Why?
| | Polymorphism, Genetic | 8 | 2015 | 657 | 0.490 |
Why?
| | Comorbidity | 15 | 2013 | 1611 | 0.490 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 5 | 2025 | 422 | 0.490 |
Why?
| | Colorado | 22 | 2024 | 4491 | 0.480 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 13 | 2025 | 241 | 0.480 |
Why?
| | Multifactorial Inheritance | 5 | 2025 | 174 | 0.470 |
Why?
| | Family | 6 | 2019 | 666 | 0.470 |
Why?
| | Depressive Disorder | 3 | 2011 | 380 | 0.420 |
Why?
| | Social Environment | 9 | 2015 | 305 | 0.420 |
Why?
| | Decision Making | 1 | 2020 | 896 | 0.410 |
Why?
| | Religion | 2 | 2010 | 70 | 0.400 |
Why?
| | Stress, Psychological | 4 | 2018 | 1098 | 0.380 |
Why?
| | Quantitative Trait Loci | 2 | 2005 | 381 | 0.380 |
Why?
| | Receptors, Nicotinic | 5 | 2025 | 335 | 0.370 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1768 | 0.370 |
Why?
| | Genomics | 3 | 2024 | 790 | 0.370 |
Why?
| | Child | 35 | 2025 | 21968 | 0.360 |
Why?
| | Genetic Association Studies | 5 | 2021 | 376 | 0.360 |
Why?
| | Risk Factors | 20 | 2025 | 10331 | 0.340 |
Why?
| | Aggression | 6 | 2022 | 204 | 0.340 |
Why?
| | Exploratory Behavior | 4 | 2013 | 91 | 0.330 |
Why?
| | Life Change Events | 1 | 2011 | 151 | 0.320 |
Why?
| | Time Factors | 3 | 2019 | 6792 | 0.310 |
Why?
| | Causality | 2 | 2020 | 127 | 0.310 |
Why?
| | Peer Group | 2 | 2008 | 244 | 0.300 |
Why?
| | Chromosome Mapping | 4 | 2008 | 523 | 0.300 |
Why?
| | Child of Impaired Parents | 2 | 2006 | 41 | 0.290 |
Why?
| | Genetics, Behavioral | 2 | 2007 | 40 | 0.290 |
Why?
| | Alleles | 8 | 2018 | 888 | 0.290 |
Why?
| | Fathers | 2 | 2006 | 50 | 0.290 |
Why?
| | Gene Frequency | 7 | 2016 | 520 | 0.290 |
Why?
| | Societies, Scientific | 1 | 2007 | 51 | 0.270 |
Why?
| | Cannabis | 3 | 2021 | 488 | 0.270 |
Why?
| | Sex Factors | 10 | 2024 | 2068 | 0.270 |
Why?
| | Age Factors | 12 | 2018 | 3290 | 0.260 |
Why?
| | Awards and Prizes | 1 | 2007 | 67 | 0.260 |
Why?
| | Opioid-Related Disorders | 2 | 2020 | 504 | 0.250 |
Why?
| | Psychotropic Drugs | 1 | 2006 | 68 | 0.240 |
Why?
| | Marijuana Smoking | 4 | 2016 | 250 | 0.240 |
Why?
| | Adoption | 3 | 2016 | 32 | 0.240 |
Why?
| | Executive Function | 2 | 2021 | 448 | 0.220 |
Why?
| | Case-Control Studies | 11 | 2019 | 3537 | 0.220 |
Why?
| | Models, Statistical | 6 | 2012 | 658 | 0.220 |
Why?
| | Genome, Human | 3 | 2020 | 424 | 0.220 |
Why?
| | Surveys and Questionnaires | 13 | 2013 | 5749 | 0.220 |
Why?
| | Epidemiologic Methods | 2 | 2004 | 96 | 0.210 |
Why?
| | Multivariate Analysis | 5 | 2016 | 1513 | 0.210 |
Why?
| | Trinucleotide Repeats | 1 | 2003 | 25 | 0.210 |
Why?
| | Bipolar Disorder | 2 | 2022 | 264 | 0.200 |
Why?
| | Sex Characteristics | 2 | 2023 | 763 | 0.200 |
Why?
| | Cultural Diversity | 1 | 2023 | 76 | 0.200 |
Why?
| | Regression Analysis | 6 | 2012 | 1024 | 0.190 |
Why?
| | Prevalence | 10 | 2012 | 2712 | 0.190 |
Why?
| | Disease | 1 | 2003 | 98 | 0.190 |
Why?
| | Mothers | 2 | 2006 | 752 | 0.190 |
Why?
| | Tobacco Use | 1 | 2022 | 65 | 0.190 |
Why?
| | Receptors, Androgen | 1 | 2003 | 149 | 0.190 |
Why?
| | Internationality | 1 | 2022 | 155 | 0.190 |
Why?
| | Genetic Linkage | 4 | 2008 | 298 | 0.190 |
Why?
| | Genetic Loci | 2 | 2022 | 288 | 0.180 |
Why?
| | Chromosomes, Human, Pair 9 | 3 | 2006 | 42 | 0.180 |
Why?
| | Chromosomes, Human, Pair 3 | 3 | 2006 | 50 | 0.180 |
Why?
| | Music | 1 | 2021 | 46 | 0.180 |
Why?
| | Biobehavioral Sciences | 1 | 2020 | 3 | 0.180 |
Why?
| | Receptors, GABA-A | 2 | 2014 | 141 | 0.170 |
Why?
| | Middle Aged | 18 | 2025 | 33200 | 0.170 |
Why?
| | NADH Dehydrogenase | 1 | 2020 | 19 | 0.170 |
Why?
| | Methyl-CpG-Binding Protein 2 | 1 | 2020 | 21 | 0.170 |
Why?
| | Pathology, Molecular | 1 | 2020 | 27 | 0.170 |
Why?
| | Students | 2 | 2023 | 624 | 0.160 |
Why?
| | Neurotransmitter Agents | 1 | 2020 | 82 | 0.160 |
Why?
| | Tobacco Products | 2 | 2019 | 142 | 0.160 |
Why?
| | Interpersonal Relations | 3 | 2019 | 404 | 0.160 |
Why?
| | Bayes Theorem | 1 | 2021 | 400 | 0.160 |
Why?
| | Illness Behavior | 1 | 2019 | 8 | 0.160 |
Why?
| | Autistic Disorder | 1 | 2022 | 201 | 0.160 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 165 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 2020 | 82 | 0.160 |
Why?
| | Nerve Tissue Proteins | 3 | 2025 | 596 | 0.150 |
Why?
| | Child Behavior Disorders | 3 | 2011 | 143 | 0.150 |
Why?
| | Child Language | 1 | 2019 | 25 | 0.150 |
Why?
| | Defense Mechanisms | 1 | 2018 | 24 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 42 | 0.150 |
Why?
| | Sexual Partners | 1 | 2020 | 189 | 0.150 |
Why?
| | Apolipoproteins E | 1 | 2019 | 83 | 0.150 |
Why?
| | Criminal Behavior | 1 | 2018 | 6 | 0.150 |
Why?
| | Expressed Emotion | 1 | 2018 | 17 | 0.150 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 98 | 0.150 |
Why?
| | Minnesota | 1 | 2019 | 161 | 0.150 |
Why?
| | Calcium-Transporting ATPases | 1 | 2018 | 40 | 0.150 |
Why?
| | Mortality, Premature | 1 | 2018 | 14 | 0.150 |
Why?
| | Motivation | 1 | 2003 | 563 | 0.150 |
Why?
| | Psychiatric Status Rating Scales | 6 | 2010 | 548 | 0.150 |
Why?
| | Educational Status | 1 | 2021 | 482 | 0.150 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2831 | 0.150 |
Why?
| | Child Behavior | 2 | 2019 | 247 | 0.140 |
Why?
| | Biological Specimen Banks | 1 | 2019 | 102 | 0.140 |
Why?
| | Parent-Child Relations | 4 | 2019 | 271 | 0.140 |
Why?
| | Intelligence | 2 | 2021 | 130 | 0.140 |
Why?
| | Cognition | 3 | 2021 | 1166 | 0.140 |
Why?
| | Receptors, Opioid, mu | 2 | 2015 | 74 | 0.130 |
Why?
| | Biomedical Research | 1 | 2023 | 689 | 0.130 |
Why?
| | Body Mass Index | 2 | 2024 | 2364 | 0.130 |
Why?
| | Sleep | 2 | 2019 | 751 | 0.130 |
Why?
| | Child Development | 1 | 2021 | 471 | 0.130 |
Why?
| | Cost of Illness | 1 | 2019 | 300 | 0.130 |
Why?
| | Prospective Studies | 8 | 2020 | 7583 | 0.130 |
Why?
| | Monoamine Oxidase | 2 | 2006 | 30 | 0.130 |
Why?
| | Gene-Environment Interaction | 2 | 2017 | 194 | 0.130 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 40 | 0.130 |
Why?
| | Linkage Disequilibrium | 6 | 2020 | 268 | 0.120 |
Why?
| | Sleep Wake Disorders | 1 | 2019 | 283 | 0.120 |
Why?
| | Microsatellite Repeats | 3 | 2006 | 167 | 0.120 |
Why?
| | Computational Biology | 1 | 2020 | 645 | 0.120 |
Why?
| | Ethanol | 3 | 2012 | 608 | 0.120 |
Why?
| | Factor Analysis, Statistical | 3 | 2011 | 286 | 0.120 |
Why?
| | Marijuana Use | 1 | 2018 | 203 | 0.110 |
Why?
| | Haplotypes | 4 | 2015 | 490 | 0.110 |
Why?
| | Likelihood Functions | 2 | 2015 | 142 | 0.110 |
Why?
| | Genome | 2 | 2006 | 291 | 0.110 |
Why?
| | Personality Tests | 2 | 2003 | 16 | 0.110 |
Why?
| | Reproducibility of Results | 7 | 2009 | 3272 | 0.100 |
Why?
| | Genetic Testing | 1 | 2016 | 452 | 0.100 |
Why?
| | Personality Disorders | 3 | 2005 | 75 | 0.100 |
Why?
| | RNA | 1 | 2020 | 924 | 0.100 |
Why?
| | Models, Psychological | 4 | 2008 | 307 | 0.100 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 31 | 0.100 |
Why?
| | Spouses | 1 | 2014 | 105 | 0.100 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2012 | 12 | 0.100 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2013 | 62 | 0.100 |
Why?
| | Personality Inventory | 3 | 2009 | 141 | 0.100 |
Why?
| | Probability | 1 | 2013 | 309 | 0.100 |
Why?
| | Body Height | 1 | 2013 | 199 | 0.090 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 23 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 991 | 0.090 |
Why?
| | Emotions | 2 | 2019 | 546 | 0.090 |
Why?
| | United States | 4 | 2020 | 14660 | 0.090 |
Why?
| | Residential Treatment | 4 | 2006 | 30 | 0.090 |
Why?
| | Psychology, Adolescent | 2 | 2009 | 66 | 0.090 |
Why?
| | Genetics, Population | 3 | 2007 | 210 | 0.090 |
Why?
| | Multigene Family | 1 | 2011 | 199 | 0.090 |
Why?
| | Binge-Eating Disorder | 1 | 2010 | 18 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2603 | 0.090 |
Why?
| | Epigenesis, Genetic | 1 | 2015 | 658 | 0.080 |
Why?
| | Parenting | 1 | 2014 | 312 | 0.080 |
Why?
| | Violence | 2 | 2018 | 262 | 0.080 |
Why?
| | Body Image | 1 | 2010 | 96 | 0.080 |
Why?
| | DNA Primers | 1 | 2010 | 513 | 0.080 |
Why?
| | Culture | 1 | 2010 | 127 | 0.080 |
Why?
| | Sample Size | 2 | 2022 | 117 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 572 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4279 | 0.070 |
Why?
| | Netherlands | 1 | 2007 | 88 | 0.070 |
Why?
| | Cohort Studies | 6 | 2018 | 5718 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 15 | 0.070 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 68 | 0.070 |
Why?
| | Risk | 2 | 2020 | 904 | 0.070 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 15 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2180 | 0.070 |
Why?
| | Schizophrenia | 2 | 2022 | 439 | 0.070 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 145 | 0.060 |
Why?
| | Personality Assessment | 4 | 2013 | 84 | 0.060 |
Why?
| | Reading | 1 | 2008 | 155 | 0.060 |
Why?
| | Social Problems | 1 | 2006 | 12 | 0.060 |
Why?
| | Psychometrics | 5 | 2009 | 721 | 0.060 |
Why?
| | Interview, Psychological | 3 | 2013 | 95 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2016 | 768 | 0.060 |
Why?
| | Perception | 1 | 2008 | 356 | 0.060 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 124 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2007 | 260 | 0.060 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2005 | 55 | 0.060 |
Why?
| | Body Weight | 1 | 2010 | 981 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2006 | 1250 | 0.060 |
Why?
| | Psychology | 1 | 2005 | 80 | 0.060 |
Why?
| | Demography | 1 | 2006 | 291 | 0.060 |
Why?
| | Gender Identity | 1 | 2005 | 124 | 0.060 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1054 | 0.050 |
Why?
| | Pedigree | 2 | 2013 | 514 | 0.050 |
Why?
| | Chi-Square Distribution | 4 | 2009 | 532 | 0.050 |
Why?
| | Lod Score | 1 | 2003 | 67 | 0.050 |
Why?
| | Marriage | 1 | 2004 | 121 | 0.050 |
Why?
| | Statistics as Topic | 3 | 2013 | 311 | 0.050 |
Why?
| | Sweden | 1 | 2003 | 101 | 0.050 |
Why?
| | Mice | 2 | 2019 | 17731 | 0.050 |
Why?
| | Cross-Sectional Studies | 4 | 2018 | 5417 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 162 | 0.050 |
Why?
| | Mendelian Randomization Analysis | 1 | 2022 | 50 | 0.050 |
Why?
| | Australia | 1 | 2003 | 314 | 0.050 |
Why?
| | Population Surveillance | 1 | 2005 | 470 | 0.050 |
Why?
| | Europe | 1 | 2022 | 414 | 0.050 |
Why?
| | Loneliness | 1 | 2022 | 44 | 0.050 |
Why?
| | Arousal | 1 | 2002 | 156 | 0.050 |
Why?
| | Depression | 2 | 2022 | 1402 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2003 | 500 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2014 | 1059 | 0.040 |
Why?
| | Interviews as Topic | 3 | 2007 | 766 | 0.040 |
Why?
| | Dangerous Behavior | 1 | 2018 | 20 | 0.040 |
Why?
| | Child, Preschool | 3 | 2022 | 11069 | 0.040 |
Why?
| | Parents | 2 | 2004 | 1355 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 648 | 0.040 |
Why?
| | Psychopathology | 1 | 2018 | 56 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2016 | 7569 | 0.040 |
Why?
| | Psychological Tests | 2 | 2010 | 138 | 0.040 |
Why?
| | United Kingdom | 1 | 2019 | 315 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 430 | 0.040 |
Why?
| | Registries | 1 | 2006 | 2015 | 0.030 |
Why?
| | Forecasting | 1 | 2019 | 384 | 0.030 |
Why?
| | Animals | 2 | 2019 | 36768 | 0.030 |
Why?
| | Maternal Behavior | 1 | 1998 | 77 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2018 | 187 | 0.030 |
Why?
| | Family Health | 1 | 1998 | 197 | 0.030 |
Why?
| | Mother-Child Relations | 1 | 1998 | 137 | 0.030 |
Why?
| | Aged | 5 | 2016 | 23729 | 0.030 |
Why?
| | Obesity | 1 | 2010 | 2975 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 971 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2016 | 36 | 0.030 |
Why?
| | Cause of Death | 1 | 2018 | 429 | 0.030 |
Why?
| | Infant | 2 | 2021 | 9442 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 357 | 0.030 |
Why?
| | Quality Control | 1 | 2016 | 171 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2021 | 15564 | 0.030 |
Why?
| | Potassium Channels | 1 | 2016 | 150 | 0.030 |
Why?
| | Cameroon | 1 | 2015 | 9 | 0.030 |
Why?
| | Asia, Southeastern | 1 | 2015 | 13 | 0.030 |
Why?
| | Singapore | 1 | 2015 | 22 | 0.030 |
Why?
| | Reward | 1 | 2017 | 243 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1260 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 181 | 0.030 |
Why?
| | Africa | 1 | 2015 | 108 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 1032 | 0.030 |
Why?
| | Receptors, Dopamine D4 | 1 | 2014 | 26 | 0.030 |
Why?
| | Catechol O-Methyltransferase | 1 | 2014 | 17 | 0.030 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 52 | 0.030 |
Why?
| | Drug Overdose | 1 | 2018 | 344 | 0.030 |
Why?
| | North America | 1 | 2015 | 313 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2019 | 651 | 0.030 |
Why?
| | Data Interpretation, Statistical | 2 | 2009 | 349 | 0.030 |
Why?
| | Algorithms | 2 | 2010 | 1686 | 0.020 |
Why?
| | Reproduction | 1 | 2013 | 203 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2750 | 0.020 |
Why?
| | Software | 1 | 2016 | 663 | 0.020 |
Why?
| | Analysis of Variance | 2 | 2007 | 1318 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 845 | 0.020 |
Why?
| | Exercise | 1 | 2021 | 2038 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4018 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2010 | 2030 | 0.020 |
Why?
| | Health Behavior | 1 | 2015 | 756 | 0.020 |
Why?
| | Nuclear Family | 1 | 2009 | 54 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1162 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2008 | 1942 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 195 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6046 | 0.020 |
Why?
| | Cannabinoids | 1 | 2010 | 161 | 0.020 |
Why?
| | Nicotine | 1 | 2010 | 336 | 0.020 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2008 | 40 | 0.020 |
Why?
| | Achievement | 1 | 2008 | 61 | 0.020 |
Why?
| | Taq Polymerase | 1 | 2006 | 10 | 0.020 |
Why?
| | Inheritance Patterns | 1 | 2006 | 47 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 1063 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 6731 | 0.020 |
Why?
| | Self Report | 1 | 2010 | 825 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 765 | 0.020 |
Why?
| | Genetic Markers | 1 | 2006 | 344 | 0.020 |
Why?
| | Child Abuse, Sexual | 1 | 2006 | 90 | 0.020 |
Why?
| | Qualitative Research | 1 | 2012 | 1359 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1281 | 0.010 |
Why?
| | Genetic Heterogeneity | 1 | 2005 | 59 | 0.010 |
Why?
| | Reference Values | 1 | 2006 | 817 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5115 | 0.010 |
Why?
| | Logistic Models | 1 | 2010 | 2060 | 0.010 |
Why?
| | Crime Victims | 1 | 2006 | 129 | 0.010 |
Why?
| | Psychomotor Agitation | 1 | 2004 | 69 | 0.010 |
Why?
| | Patient Selection | 1 | 2008 | 689 | 0.010 |
Why?
| | Self Concept | 1 | 2004 | 252 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1499 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2002 | 409 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2005 | 1483 | 0.010 |
Why?
| | Incidence | 1 | 2008 | 2788 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2001 | 328 | 0.010 |
Why?
| | Selection, Genetic | 1 | 2002 | 262 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 973 | 0.010 |
Why?
| | Risk Assessment | 1 | 2009 | 3429 | 0.010 |
Why?
| | Paternal Deprivation | 1 | 1998 | 4 | 0.010 |
Why?
| | Hemoglobins, Abnormal | 1 | 1978 | 11 | 0.010 |
Why?
| | Crime | 1 | 1998 | 60 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 2045 | 0.010 |
Why?
| | Genes | 1 | 1978 | 230 | 0.010 |
Why?
| | Long-Term Care | 1 | 1998 | 100 | 0.010 |
Why?
| | Motor Activity | 1 | 2002 | 719 | 0.010 |
Why?
| | Heterozygote | 1 | 1978 | 292 | 0.010 |
Why?
| | Models, Biological | 1 | 2003 | 1769 | 0.010 |
Why?
| | Mass Screening | 1 | 2004 | 1262 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1978 | 433 | 0.010 |
Why?
| | Thalassemia | 1 | 1978 | 7 | 0.000 |
Why?
| | Globins | 1 | 1978 | 22 | 0.000 |
Why?
| | Hemolysis | 1 | 1978 | 205 | 0.000 |
Why?
| | Kinetics | 1 | 1978 | 1668 | 0.000 |
Why?
|
|
Stallings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|